As of May 05
| -1.23 / -2.87%|
The 30 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 42.18, with a high estimate of 51.55 and a low estimate of 28.50. The median estimate represents a +1.27% increase from the last price of 41.65.
The current consensus among 34 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.